Conclusion: SA can regulate the intestinal microbial balance and metabolic disorder by inhibiting the NLRP3/ASC/caspase-1 axis to relieve NASH. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatohepatitis.